NCT06040268 - Advair HFA in Healthy and HAPE Predisposed Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 15, 2026

Conditions

Altitude Edema

Interventions

DRUG

Advair HFA

6 puffs (total: salmeterol 126 ug and fluticasone 270 ug) twice daily

DRUG

Placebo

HFA134a inhaler

Trial Locations (1)

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

University of Colorado, Denver

OTHER